KRAS and neoplasm: Analysis of tumor gene expression data sets has shown that mutant KRAS status is associated with reduced infiltration of cytotoxic T cells and suppression of the adaptive IFN-γ response in CRC [30], and a possible mechanism for mutant KRAS-driven CRC immune tolerance was recently reported [31].